{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:47Z","timestamp":1786985027034,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bbr.2018.10.032","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:22:59Z","timestamp":1540210979000},"page":"353-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity"],"prefix":"10.1016","volume":"359","author":[{"given":"Toshiko","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tsunekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Satoyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuko","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2018.10.032_bib0005","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2018.10.032_bib0010","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.bbr.2018.10.032_bib0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/ajp.2006.163.9.1531","article-title":"Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: A STAR*D report","volume":"163","author":"McGrath","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2018.10.032_bib0020","series-title":"Practice Guideline for the Treatment of Patients With Major Depressive Disorder","author":"Gelenberg","year":"2010"},{"key":"10.1016\/j.bbr.2018.10.032_bib0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(77)91940-7","article-title":"Implications of combined treatment with \u201cMadopar\u201d and L-deprenil in Parkinson\u2019s disease. A long-term study","volume":"309","author":"Birkmayer","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2018.10.032_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archpsyc.1989.01810010047007","article-title":"A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor","volume":"46","author":"Mann","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2018.10.032_bib0035","first-page":"63","article-title":"A placebo-controlled trial of L-deprenyl in atypical depression","volume":"25","author":"McGrath","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.bbr.2018.10.032_bib0040","first-page":"527","article-title":"Transdermal selegiline for the treatment of major depressive disorder","volume":"3","author":"Lee","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2018.10.032_bib0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/npp.2014.214","article-title":"Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain","volume":"40","author":"Fowler","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2018.10.032_bib0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/17425247.2016.1140145","article-title":"Critical appraisal of selegiline transdermal system for major depressive disorder","volume":"13","author":"Cristancho","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bbr.2018.10.032_bib0055","doi-asserted-by":"crossref","first-page":"14065","DOI":"10.1073\/pnas.93.24.14065","article-title":"Brain monoamine oxidase A inhibition in cigarette smokers","volume":"93","author":"Fowler","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1503\/jpn.100117","article-title":"Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study","volume":"36","author":"Sacher","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0065","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2147\/NDT.S49261","article-title":"Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report","volume":"9","author":"Kitaichi","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2018.10.032_bib0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.jcp.0000270085.15253.15","article-title":"Treatment-resistant depression: response to low-dose transdermal but not oral selegiline","volume":"27","author":"Morgan","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40263-013-0097-3","article-title":"Current place of monoamine oxidase inhibitors in the treatment of depression","volume":"27","author":"Shulman","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2018.10.032_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2018.10.032_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2018.10.032_bib0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2018.10.032_bib0100","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/bbrc.2000.4037","article-title":"Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes","volume":"279","author":"Mizuta","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbr.2018.10.032_bib0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10571-009-9458-3","article-title":"Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo","volume":"30","author":"Gy\u00e1rf\u00e1s","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0110","first-page":"549","article-title":"Effect of selegiline on neural stem cells differentiation: a possible role for neurotrophic factors","volume":"18","author":"Hassanzadeh","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0115","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.bbr.2018.10.032_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbr.2005.10.019","article-title":"Evaluation of two genetic animal models in behavioral tests of anxiety and depression","volume":"168","author":"Hinojosa","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.10.032_bib0125","first-page":"348","article-title":"Adaptation of the tail suspension test to the rat","volume":"17","author":"Chermat","year":"1986","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2007.12.016","article-title":"Effects of (R)-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in animal models of mood disorders","volume":"189","author":"Tsunekawa","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.10.032_bib0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbr.2018.03.002","article-title":"Selegiline increases on time without exacerbation of dyskinesia in 6-hydroxydopamine-lesioned rats displaying L-Dopa-induced wearing-off and abnormal involuntary movements","volume":"347","author":"Tsunekawa","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.10.032_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2018.10.032_bib0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnbeh.2017.00075","article-title":"Selegiline ameliorates depression-like behavior in mice lacking the CD157\/BST1 gene, a risk factor for Parkinson\u2019s disease","volume":"11","author":"Kasai","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1254\/jphs.12023FP","article-title":"Possible modulation of the amygdala on metaplasticity deficits in the hippocampal CA1 field in early postnatally stressed rats","volume":"119","author":"Hiraide","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0155","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.bbr.2018.10.032_bib0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.euroneuro.2005.02.003","article-title":"Antidepressant-like effects of selegiline in the forced swim test","volume":"15","author":"Shimazu","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1353-8020(01)00011-6","article-title":"Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson\u2019s disease","volume":"8","author":"Youdim","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbr.2018.10.032_bib0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/syn.20631","article-title":"Possible relationship between the stress-induced synaptic response and metaplasticity in the hippocampal CA1 field of freely moving rats","volume":"63","author":"Hirata","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2018.10.032_bib0180","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cell.2012.06.052","article-title":"Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction","volume":"150","author":"Liu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2018.10.032_bib0185","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuint.2012.01.021","article-title":"Involvement of glucocorticoid-mediated Zn2+ signaling in attenuation of hippocampal CA1 LTP by acute stress","volume":"60","author":"Takeda","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2018.10.032_bib0190","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1038\/srep15000","article-title":"Despair-associated memory requires a slow-onset CA1 long-term potentiation with unique underlying mechanisms","volume":"5","author":"Jing","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2018.10.032_bib0195","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/387497a0","article-title":"Behavioural stress facilitates the induction of long-term depression in the hippocampus","volume":"387","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2018.10.032_bib0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cercor\/bhs362","article-title":"Dopamine D1\/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity","volume":"24","author":"Hansen","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbr.2018.10.032_bib0205","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1523\/JNEUROSCI.22-09-03638.2002","article-title":"Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents","volume":"22","author":"Shakesby","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yhbeh.2014.02.002","article-title":"The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test","volume":"65","author":"Solomon","year":"2014","journal-title":"Horm. Behav."},{"key":"10.1016\/j.bbr.2018.10.032_bib0220","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.95.6.3204","article-title":"Glucocorticoid receptor and protein\/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress","volume":"95","author":"Xu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2018.10.032_bib0225","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/ene.12724","article-title":"A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson\u2019s disease patients","volume":"22","author":"Barone","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0230","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bjp.0702389","article-title":"Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo","volume":"126","author":"Lamensdorf","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0235","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/mp.2016.127","article-title":"The significance of selegiline\/(-)-deprenyl after 50 years in research and therapy (1965-2015)","volume":"21","author":"Miklya","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.10.032_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011382","article-title":"Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus","volume":"5","author":"Swant","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2018.10.032_bib0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbr.2014.08.040","article-title":"Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression","volume":"275","author":"Qiao","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.10.032_bib0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0301-0082(03)00085-6","article-title":"Dopamine: a potential substrate for synaptic plasticity and memory mechanisms","volume":"69","author":"Jay","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0255","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1523\/JNEUROSCI.1454-06.2006","article-title":"Dopamine D1\/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression","volume":"26","author":"Lemon","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1101\/lm.63806","article-title":"Dopamine transporter blockade increases LTP in the CA1 region of the rat hippocampus via activation of the D3 dopamine receptor","volume":"13","author":"Swant","year":"2006","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbr.2018.10.032_bib0265","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00001756-200105080-00025","article-title":"Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells","volume":"12","author":"K\u00fcppers","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2018.10.032_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.vh.2016.10.004","article-title":"BDNF and hippocampal synaptic plasticity","volume":"104","author":"Leal","year":"2017","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbr.2018.10.032_bib0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.physbeh.2016.04.052","article-title":"Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse","volume":"163","author":"Amiri","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2018.10.032_bib0280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(01)02062-6","article-title":"Chronic imipramine treatment partially reverses the long-term changes of hippocampal synaptic plasticity in socially stressed rats","volume":"309","author":"Von Frijtag","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2018.10.032_bib0285","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00213-004-2094-1","article-title":"Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress","volume":"179","author":"Matsumoto","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2018.10.032_bib0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-3956(00)00040-6","article-title":"Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice","volume":"35","author":"Steckler","year":"2001","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2018.10.032_bib0295","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pnpbp.2014.12.002","article-title":"Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory","volume":"58","author":"B\u00e9try","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.10.032_bib0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.25724","article-title":"PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity","volume":"29","author":"Madeo","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2018.10.032_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2018.10.032_bib0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/neuro.09.026.2009","article-title":"Cognitive functioning in major depression \u2013 a summary","volume":"3","author":"Hammar","year":"2009","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.bbr.2018.10.032_bib0315","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pharep.2013.11.003","article-title":"Essential difference between the pharmacological spectrum of (-)-deprenyl and rasagiline","volume":"66","author":"Miklya","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2018.10.032_bib0320","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2005.06.024","article-title":"Effects of selegiline alone or with donepezil on memory impairment in rats","volume":"518","author":"Takahata","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.10.032_bib0325","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643281831235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643281831235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T08:43:50Z","timestamp":1662281030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643281831235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":65,"alternative-id":["S016643281831235X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.10.032","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}